Impacts of curcumin nanoemulgel on cell viability and apoptotic pathways: a comprehensive study of ROS generation across different skin cancer cell lines.

Authors

Joshna Booravilli, Janaki Devi Sirisolla

Published in

Nanomedicine (London, England). Pages 1-17. Jun 21, 2026. Epub Jun 21, 2026.

Abstract

Conventional curcumin formulations, such as gels, creams, and oral dosage forms, have poor solubility and bioavailability, limiting its therapeutic efficiency. Therefore, the primary objective of this research work was to formulate a curcumin nanoemulgel to increase the solubility and therapeutic efficacy of curcumin and evaluate its cytotoxic, apoptotic, and Reactive oxygen species (ROS) activities against various cell lines.
A curcumin nanoemulgel was formulated by adding the optimized curcumin nanoemulsion to plain carbopol gel and then subjected to various evaluation studies.
The optimized curcumin nanoemulgel exhibited better growth suppression of cancer cell lines, especially in A431 squamous cell carcinoma cells, with an inhibition percentage of 66.52 ± 1.3% an IC₅₀ value of 123.30 µM. Flow cytometry analysis revealed that curcumin nanoemulgel promoted apoptosis, with larger percentages of late apoptotic cells in A431 cells. The dual AO/EB fluorescence microscopy revealed distinctive apoptotic characteristics, including chromatin condensation, nuclear fragmentation, membrane blebbing, and the formation of apoptotic bodies.
All of these results demonstrate that the nanoemulgel formulation is a superior therapeutic choice as it not only enhances curcumin's anticancer effectiveness but also ensures its safety in healthy cells.

PMID:
42324741
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.